Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Novo Nordisk
Biotech
Lilly’s weekly insulin hits primary endpoint in 2 pivotal trials
Lilly kept itself in Novo's slipstream Thursday with positive top-line data from a pair of phase 3 studies of its once-weekly insulin candidate.
Nick Paul Taylor
May 16, 2024 6:45am
Novo Nordisk's Hemlibra rival hits goals in phase 3
May 14, 2024 9:16am
Novo Nordisk pens $600M obesity pact with Flagship's Metaphore
May 9, 2024 7:00am
Novo Nordisk Foundation inks R&D pact for global health issues
May 6, 2024 10:59am
UPDATE: Amgen axes an obesity asset, zooms in on MariTide
May 2, 2024 6:16pm
Regeneron, Lilly grapple with clinical endpoints in obesity
May 2, 2024 10:38am